FDA approves pembrolizumab for resectable head and neck most cancers with PD-L1 expression
Credit score: Unsplash/CC0 Public Area Pembrolizumab, an immune checkpoint inhibitor, has been…
Medical trial exhibits immunotherapy drug pembrolizumab improves outcomes for sufferers with comfortable tissue sarcoma
Credit score: CC0 Public Area Addition of the immunotherapy drug pembrolizumab to…
